Evidence map›Paper›PMID 36978820›Full record

ArticleAntioxidants (Basel, Switzerland)2023

Charlotte Segers, Mohamed Mysara, Amelie Coolkens, Shari Wouters, Sarah Baatout, Natalie Leys, Sarah Lebeer, Mieke Verslegers, Felice Mastroleo

Open access · goldFull text read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Charlotte SegersInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0001-7546-2961
Mohamed MysaraInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0001-5746-4330
Amelie CoolkensInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.
Shari WoutersInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0002-7259-6945
Sarah BaatoutInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0001-8110-751X
Natalie LeysInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0002-4556-5211
Sarah LebeerDepartment of Bioscience Engineering, University of Antwerp, 2020 Antwerp, Belgium.ORCID 0000-0002-9400-6918
Mieke VerslegersInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.
Felice MastroleoInterdisciplinary Biosciences Group, Belgian Nuclear Research Centre, SCK CEN, 2400 Mol, Belgium.ORCID 0000-0002-9815-8038
Belgian Nuclear Research Centre · BEUniversity of Antwerp · BE

Funding

Belgian Nuclear Research Centre 2017 PhD Grant program
6 · The paper itself

Abstract

Pelvic irradiation-induced mucositis secondarily leads to dysbiosis, which seriously affects patients' quality of life after treatment. No safe and effective radioprotector or mitigator has yet been approved for clinical therapy. Here, we investigated the potential protective effects of fresh biomass of

Indexed as

bacterial dietary supplementdysbiosisintestineionizing radiationmicrobiomemicrobiotamucositisradiomitigator

Identifiers

PMID36978820
PMCPMC10045453
OpenAlexW4322500585

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read18
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.